Cargando…

Landscape of natural killer cell activity in head and neck squamous cell carcinoma

Head and neck squamous cell carcinoma (HNSCC) encompasses a set of cancers arising from the epithelia of the upper aerodigestive tract, accounting for a significant burden of disease worldwide due to the disease’s mortality, morbidity, and predilection for recurrence. Prognosis of HNSCC in the recur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Charap, Andrew J, Enokida, Tomohiro, Brody, Rachel, Sfakianos, John, Miles, Brett, Bhardwaj, Nina, Horowitz, Amir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754625/ https://www.ncbi.nlm.nih.gov/pubmed/33428584 http://dx.doi.org/10.1136/jitc-2020-001523

Ejemplares similares

Head and Neck Squamous Cell Carcinoma: Epigenetic Landscape
por: Romanowska, Kamila, et al.
Publicado: (2020)

Natural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma
por: Weil, Sandra, et al.
Publicado: (2017)

The non-coding landscape of head and neck squamous cell carcinoma
por: Zou, Angela E., et al.
Publicado: (2016)

Paclitaxel Plus Cetuximab as 1st Line Chemotherapy in Platinum-Based Chemoradiotherapy-Refractory Patients With Squamous Cell Carcinoma of the Head and Neck
por: Enokida, Tomohiro, et al.
Publicado: (2018)

Novel Insight into Mutational Landscape of Head and Neck Squamous Cell Carcinoma
por: Gaykalova, Daria A., et al.
Publicado: (2014)

Head and Neck Squamous Cell Carcinoma Vaccine: Current Landscape and Perspectives
por: Meliante, Piero Giuseppe, et al.
Publicado: (2023)

Predictive Value of Cetuximab-Induced Skin Toxicity in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NECK
por: Uozumi, Shinya, et al.
Publicado: (2018)

Electrochemotherapy in the Treatment of Head and Neck Cancer: Current Conditions and Future Directions
por: Enokida, Tomohiro, et al.
Publicado: (2021)

Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition
por: Crist, McKenzie, et al.
Publicado: (2022)

Correction: Novel Insight into Mutational Landscape of Head and Neck Squamous Cell Carcinoma
por: Gaykalova, Daria A., et al.
Publicado: (2020)

The Landscape of Somatic Copy Number Alterations in Head and Neck Squamous Cell Carcinoma
por: Yang, Jian, et al.
Publicado: (2020)

Impaired intratumoral natural killer cell function in head and neck carcinoma
por: Mele, Dalila, et al.
Publicado: (2022)

Characterization of the Immune Cell Infiltration Landscape in Head and Neck Squamous Cell Carcinoma to Aid Immunotherapy
por: Zhang, Xinhai, et al.
Publicado: (2020)

Heterogeneity of the Head and Neck Squamous Cell Carcinoma Immune Landscape and Its Impact on Immunotherapy
por: Canning, Madison, et al.
Publicado: (2019)

Mutational landscape of head and neck squamous cell carcinomas in a South Asian population
por: Ghias, Kulsoom, et al.
Publicado: (2019)

Development of an Immunogenomic Landscape-Based Prognostic Index of Head and Neck Squamous Cell Carcinoma
por: Long, Jinhua, et al.
Publicado: (2020)

Merkel Cell Carcinoma of the Head and Neck: Challenges in Diagnosis and Therapy
por: Miles, Brett A.
Publicado: (2013)

Activation of Natural Killer Cells during Microbial Infections
por: Horowitz, Amir, et al.
Publicado: (2012)

Cetuximab-induced natural killer cell cytotoxicity in head and neck squamous cell carcinoma cell lines: investigation of the role of cetuximab sensitivity and HPV status
por: Baysal, Hasan, et al.
Publicado: (2020)

Comprehensive Landscape of Prognostic Significance and Immune Characteristics of Myosins in Squamous Cell Carcinoma of the Head and Neck
por: Zhu, Yuying, et al.
Publicado: (2022)

Current landscape of clinical trials for HPV-positive head and neck squamous cell carcinoma (HNSCC)
por: Bteich, Yara T, et al.
Publicado: (2022)

CDX2 enhances natural killer cell–mediated immunotherapy against head and neck squamous cell carcinoma through up‐regulating CXCL14
por: Wang, Haitao, et al.
Publicado: (2021)

A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma
por: Tahara, Makoto, et al.
Publicado: (2021)

Identification of the Immune Cell Infiltration Landscape in Head and Neck Squamous Cell Carcinoma (HNSC) for the Exploration of Immunotherapy and Prognosis
por: Huang, Chunli, et al.
Publicado: (2022)

Understanding the tumor microenvironment in head and neck squamous cell carcinoma
por: Rad, Habib Sadeghi, et al.
Publicado: (2022)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

The Molecular Landscape and Biological Alterations Induced by PRAS40-Knockout in Head and Neck Squamous Cell Carcinoma
por: Chen, Gang, et al.
Publicado: (2021)

Investigation of an FGFR-Signaling-Related Prognostic Model and Immune Landscape in Head and Neck Squamous Cell Carcinoma
por: Chen, Qi, et al.
Publicado: (2022)

Genomic Landscape of Head and Neck Squamous Cell Carcinoma Across Different Anatomic Sites in Chinese Population
por: Ju, Yunhe, et al.
Publicado: (2021)

Immune-Related lncRNA Signature for Predicting the Immune Landscape of Head and Neck Squamous Cell Carcinoma
por: Yin, Ji, et al.
Publicado: (2021)

Identification of cuproptosis‐related subtypes and characterization of the tumor microenvironment landscape in head and neck squamous cell carcinoma
por: Huang, Juntao, et al.
Publicado: (2022)

Characterization of the immune cell function landscape in head and neck squamous carcinoma to assist in prognosis prediction and immunotherapy
por: Wang, Wenlun, et al.
Publicado: (2023)

Cutaneous Squamous Cell Carcinoma of the Head and Neck
por: Gurudutt, Vivek V., et al.
Publicado: (2011)

Hypoxia in Head and Neck Squamous Cell Carcinoma
por: Li, John Zenghong, et al.
Publicado: (2012)

Immunotherapy for head and neck squamous cell carcinoma
por: Fuereder, Thorsten
Publicado: (2016)

Immunotherapy for Head and Neck Squamous Cell Carcinoma
por: Moskovitz, Jessica, et al.
Publicado: (2018)

Immunotherapy in Head and Neck Squamous Cell Cancer
por: Denaro, Nerina, et al.
Publicado: (2018)

Exosomes in Head and Neck Squamous Cell Carcinoma
por: Xiao, Cheng, et al.
Publicado: (2019)

Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma
por: Nohata, N, et al.
Publicado: (2013)

Incidence and Risk Factors of Hypomagnesemia in Head and Neck Cancer Patients Treated with Cetuximab
por: Enokida, Tomohiro, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0jipgv1co737kulpmaeo40d7h4